A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer.
View / Open Files
Authors
Millstein, Joshua
Budden, Timothy
Anglesio, Michael
Talhouk, Aline
Beeghly-Fadiel, Alicia
Berchuck, Andrew
Chenevix-Trench, Georgia
deFazio, Anna
Fasching, Peter A
Gayther, Simon
Garcia, Maria
Goode, Ellen L
Henderson, Michelle
Konecny, Gottfried E
Orsulic, Sandra
Huntsman, David
Bowtell, David
Doherty, Jennifer
Ramus, Susan J
Publication Date
2018-05-20Journal Title
JOURNAL OF CLINICAL ONCOLOGY
ISSN
0732-183X
Volume
36
Issue
15
Type
Conference Object
This Version
AM
Metadata
Show full item recordCitation
Millstein, J., Budden, T., Anglesio, M., Talhouk, A., Beeghly-Fadiel, A., Berchuck, A., Chenevix-Trench, G., et al. (2018). A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer.. JOURNAL OF CLINICAL ONCOLOGY, 36 (15)https://doi.org/10.1200/JCO.2018.36.15_suppl.5583
Sponsorship
Cancer Research UK (16561)
National Institutes of Health (NIH) (via H Lee Moffitt Cancer Center & Research Institute) (SUBAWARD # 10-15915-01-03-G2)
Congressionally Directed Medical Research Programs (CDMRP) (via (BD521555)
National Institutes of Health (NIH) (via Cedars-Sinai Medical Center) (sub award 0001331845)
H. Lee Moffitt Cancer Center & Research Institute (8604)
Identifiers
External DOI: https://doi.org/10.1200/JCO.2018.36.15_suppl.5583
This record's URL: https://www.repository.cam.ac.uk/handle/1810/315175
Rights
All rights reserved